Drug Interactions between mobocertinib and pomalidomide
This report displays the potential drug interactions for the following 2 drugs:
- mobocertinib
- pomalidomide
Interactions between your drugs
No interactions were found between mobocertinib and pomalidomide. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
mobocertinib
A total of 518 drugs are known to interact with mobocertinib.
- Mobocertinib is in the drug class EGFR inhibitors.
- Mobocertinib is used to treat Non-Small Cell Lung Cancer.
pomalidomide
A total of 378 drugs are known to interact with pomalidomide.
- Pomalidomide is in the following drug classes: miscellaneous antineoplastics, other immunosuppressants.
- Pomalidomide is used to treat the following conditions:
Drug and food interactions
mobocertinib food
Applies to: mobocertinib
You should avoid consumption of grapefruit and grapefruit juice during treatment with mobocertinib. Grapefruit juice can increase the blood levels of mobocertinib. This may increase the risk of side effects such as diarrhea, nausea, vomiting, rash, fatigue, musculoskeletal pain, mouth sores and inflammation, heart failure, and rare but potentially serious and life-threatening irregular heart rhythm disorders. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
pomalidomide food
Applies to: pomalidomide
If you are a smoker, you should be aware that cigarette smoking may reduce the blood levels and effects of pomalidomide. Talk to your health care professional if you have any questions or concerns. Pomalidomide should be taken with water the same time everyday on an empty stomach, at least 2 hours before or 2 hours after a meal. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.